charles river laboratories international inc. Resources | BNET
On TechRepublic: 5 habits of wildly unsuccessful CIOs

BNET Industries

Charles River Laboratories International Inc. (CRL) is in the Pharma Industry

Revenue
Dec 29 2007
$1.2B
Profit
Dec 29 2007
$154.4M
Market Cap
Jul 02 2008
$4.3B

Latest News and Analysis

Additional Resources

  • Charles River to Present at Jefferies Healthcare Conference

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2nd Annual Healthcare Conference in New York, New York on Wednesday, June 25th at 9:00 a.m. ET. Management will present an overview of Charles River's strategic focus and business developments. ...

    Articles 2008-06-23

  • Charles River to Present at William Blair Growth Stock Conference

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster will present at the William Blair 28th Annual Growth Stock Conference in Chicago, Illinois on Wednesday, June 18th at 8:30 a.m. CT (9:30 a.m. ET). Mr. Foster will present...

    Articles 2008-06-16

  • Charles River to Present at Goldman Sachs Healthcare Conference

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Goldman Sachs 29th Annual Global Healthcare Conference in Dana Point, California on Wednesday, June 11th at 10:00 a.m. PT (1:00 p.m. ET). Mr. Ackerman...

    Articles 2008-06-09

  • Charles River to Webcast Investor Meeting

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it will hold a meeting for the investment community with its management team on Wednesday, June 4, 2008. Investors as well as the general public are invited to listen to a live webcast of the meeting which is...

    Articles 2008-06-02

  • Charles River to Present at Bank of America and Baird Conferences

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it will present at two upcoming conferences. Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Bank of America 2008 Health Care Conference in Las Vegas, Nevada, on Tuesday, May 13, 2008 at...

    Articles 2008-05-12

  • Charles River Announces First-Quarter 2008 Results

    - First-Quarter Sales Increase 16% to $338 Million Due to Strong Customer Demand - - First-Quarter GAAP EPS of $0.64 and Non-GAAP EPS of $0.72 - - Reaffirms Guidance for 2008 - WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) today reported...

    Articles 2008-05-06

  • Charles River Schedules First-Quarter 2008 Earnings Release and Conference Call

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2008 financial results on Tuesday, May 6th after the market closes. A conference call has been scheduled to discuss the results on Wednesday, May 7th at 8:30 a.m. ET. Investors will have the opportunity to...

    Articles 2008-04-07

  • Charles River to Present at Cowen and Lehman Brothers Conferences

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it will present at the two upcoming healthcare conferences. On Tuesday, March 18th at 10:15 a.m. ET, Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Cowen and Company 28th Annual Health Care...

    Articles 2008-03-17

  • Charles River Laboratories to Present at Raymond James Conference

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster will present at the Raymond James 29th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 4that 1:05 p.m. ET. Mr. Foster will present an overview of Charles...

    Articles 2008-03-03

  • Has added Charles River Laboratories International Inc. to their watch list.

    M2 PRESSWIRE-12 February 2008-MG Strategies: Has added Charles River Laboratories International Inc. to their watch list.C1994-2008 M2 COMMUNICATIONS LTD RDATE:12022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants,...

    Articles 2008-02-12

  • Charles River Announces Fourth-Quarter and Full-Year 2007 Results from Continuing Operations

    - Strong Customer Demand Drives Double-Digit Sales and Earnings Growth - - Fourth-Quarter Sales Increase 17.0% and Full Year Rises 16.3% to $1.23 Billion - - Fourth-Quarter GAAP EPS of $0.55 and Non-GAAP EPS of $0.65 - - 2007 GAAP EPS of $2.29 and...

    Articles 2008-02-11

  • Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU

    To: LABOR EDITORS Contact: Jeff Hall of 1199 SEIU United Healthcare Workers East,+1-877-409-1199 x102, cell: +1-617-281-8384 Union asks board member to seek restatement of Beth IsraelDeaconess Medical Center audit BOSTON, Feb. 6 /PRNewswire-USNewswire/ -- Charles RiverLaboratories International director Stephen Chubb should apply thesame Sarbanes-Oxley standards used by Charles River...

    Articles 2008-02-06

  • Charles River to Present at Wachovia 2008 Healthcare Conference

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Wachovia 2008 Healthcare Conference in Boston, Massachusetts on Wednesday, January 30th, at 9:00 a.m. ET. Mr. Ackerman will present an overview of Charles River's...

    Articles 2008-01-28

  • Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2007 Earnings Release and Conference Call

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) will release fourth-quarter and full-year 2007 financial results on Monday, February 11th after the market closes. A conference call has been scheduled to discuss the results on Tuesday, February 12th at 8:30 a.m. ET. Investors will have the opportunity...

    Articles 2008-01-17

  • Charles River Laboratories to Present at 26th Annual JPMorgan Healthcare Conference

    WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster and Executive Vice President and Chief Financial Officer Thomas F. Ackerman will present at the JPMorgan Healthcare Conference in San Francisco, California on Tuesday, January 8th at 10:00 a.m....

    Articles 2008-01-07

  • Incorporated: 1994
  • CEO: Mr. James C. Foster

Charles River Laboratories International is a provider of services that advance the drug discovery and development process. Co. has two reporting segments: Research Models and Services is engaged in production and sale of research models, principally genetically and virally defined purpose-bred rats and mice; Co.'s Preclinical Services provides in vivo and in vitro studies, supportive laboratory services, and strategic preclinical consulting and program management to support new drug development. As of Dec 31 2007, Co. operated approximately 60 facilities, including its production and warehousing facilities, throughout 15 countries worldwide.

Key Competitors

advertisement
Charles River Laboratories International Inc. Company Info

Board of Directors

Mr. James C. Foster

Chairman

Dr. Nancy T. Chang

Mr. Stephen D. Chubb

Mr. C. Richard Reese

Mr. George E. Massaro

Dr. George M. Milne Jr., Ph.

Mr. Douglas E. Rogers

Dr. Samuel O. Thier M.D.

Mr. William H. Waltrip

Contact Information

251 Ballardvale Street

Wilmington, MA

http://www.criver.com

781 222-6000

NAICS Code

Biological Product (except Diagnostic) Manufacturing: 325414
advertisement